The Monogram acquisition will contribute to revenue growth in 2027 by improving Zimmer Biomet's robotic knee adoption in the U.S.

The move is expected to bolster Zimmer’s ROSA Robotics platform with Monogram's semi-autonomous and fully autonomous robotic technologies.

--Zimmer Biomet Holdings, Inc., a global medical technology leader, and Monogram Technologies Inc., an orthopedic robotics company, today announced they have entered into a definitive agreement ...

Upon closing of the proposed transaction, Zimmer Biomet expects to have a clear pathway to become the first and only company in orthopedics to offer a fully autonomous surgical robot.

Zimmer Biomet and Monogram undertake no obligation to update any of these forward-looking statements as the result of new information or to reflect events or circumstances after the date of this ...

Zimmer Biomet , a medical technology company, and Monogram Technologies , an orthopedic robotics company, has entered into a definitive agreement for Zimmer Biomet to acquire all outstanding ...

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) reported net sales of $1.909 million in Q1, reflecting a 1.1% increase on a reported basis and a 2.3% rise when excluding the effects of foreign currency. While ...

Investing.com - Citi has reiterated its Neutral rating and $104.00 price target on Zimmer Biomet (NYSE:ZBH), currently trading near its 52-week low at $93.99, following the company’s ...

Zimmer Biomet Holdings, Inc., a global medical technology leader, and Monogram Technologies Inc., an orthopaedic robotics company, announced they have entered into a definitive agreement for Zimmer ...